Position in RPRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$144,479,604
+$106,678,190 QoQ
Shares Held
2,576,772
+227.0% QoQ
Ownership
0.448%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#27
of 646 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. RPRX ranks #2 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,479,604 | 2,576,772 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $37,801,414 | 788,022 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $31,401,297 | 812,663 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $27,377,244 | 775,999 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $23,635,499 | 655,995 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $2,901,190 | 93,196 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $708,998 | 27,793 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $16,380,531 | 579,022 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $649,783 | 24,641 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $748,347 | 24,641 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $636,828 | 22,671 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $615,290 | 22,671 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $696,906 | 22,671 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $792,732 | 22,002 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $833,476 | 21,090 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $881,951 | 21,950 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $874,810 | 20,809 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $12,730,335 | 326,754 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $12,654,088 | 317,543 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $5,128,085 | 141,895 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $245,858 | 5,998 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $261,632 | 5,998 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $300,199 | 5,998 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||